Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay

author
created [InstanceEdit:9684954] Jassal, Bijay, 2020-04-22
dbId 9684962
displayName Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
journal Antimicrob. Agents Chemother.
pages 6532-6539
pubMedIdentifier 27550352
schemaClass LiteratureReference
title Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
url http://www.ncbi.nlm.nih.gov/pubmed/27550352
volume 60
year 2016
Cite Us!